Acacia subsidiary receives patents for wireless physiological monitoring technology Acacia Research Company announced today a subsidiary has acquired 11 patents for wi-fi physiological monitoring technology. Acacia is quickly becoming the first choice in technology licensing and we continue to grow our base of future revenues by adding new patent portfolios, concluded Mr. Ryan. This patented technology generally relates to the wireless transmission of physiological data such as for example heart rate and blood circulation pressure. This technology provides applications such as monitoring of implantable gadgets, in addition to home healthcare and fitness systems.Method: Patients were selected from a occupied rhinology tertiary care middle. To ESS Prior, participants received a depression level and a SNOT-20 sinonasal symptomatology questionnaire, and endoscopic ratings were noted. Individuals repeated questionnaires at 6 weeks and three months after ESS. Endoscopic ratings were noted at all three appointments. Results: The most useful instrument to predict outcomes was the SNOT-20 scale. The SNOT-20 scale was extremely correlated with the HDS. ESS did not result in any significant adjustments in apatient’s rating on HDS, but SNOT-20 scales had been improved by it. Patients with lower preoperative ideals on HDS had significantly better surgical outcomes as described by Lund-Kennedy and SNOT-20. Higher preoperative values on HDS had less improvement in Lund-Kennedy and SNOT-20 significantly.